Evidence map›Paper›PMID 33800913›Full record

ArticleGenes2021

Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing.

Jia Zhou, Ziying Yang, Jun Sun, Lipei Liu, Xinyao Zhou, Fengxia Liu, Ya Xing, Shuge Cui, Shiyi Xiong, Xiaoyu Liu and 14 more

Abstract readComparative Study
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Performance of international phenotypic criteria for prenatal exome sequencing: systematic review and comparative diagnostic accuracy study using historical individual participant data.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Systematic method for classifying multiple congenital anomaly cases in electronic health records.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jia ZhouShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Ziying YangBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Jun SunBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Lipei LiuBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Xinyao ZhouShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Fengxia LiuBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Ya XingShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Shuge CuiBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Shiyi XiongShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Xiaoyu LiuBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Yingjun YangShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Xiuxiu WeiBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Gang ZouShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Zhonghua WangBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Xing WeiShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Yaoshen WangBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.ORCID 0000-0003-2034-3855
Yun ZhangShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Saiying YanBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Fengyu WuShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Fanwei ZengBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Jian WangDepartment of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
Tao DuanShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Zhiyu PengBGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.
Luming SunShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole genome sequencing (WGS) is a powerful tool for postnatal genetic diagnosis, but relevant clinical studies in the field of prenatal diagnosis are limited. The present study aimed to prospectively evaluate the utility of WGS compared with chromosomal microarray (CMA) and whole exome sequencing (WES) in the prenatal diagnosis of fetal structural anomalies. We performed trio WGS (≈40-fold) in parallel with CMA in 111 fetuses with structural or growth anomalies, and sequentially performed WES when CMA was negative (CMA plus WES). In comparison, WGS not only detected all pathogenic genetic variants in 22 diagnosed cases identified by CMA plus WES, yielding a diagnostic rate of 19.8% (22/110), but also provided additional and clinically significant information, including a case of balanced translocations and a case of intrauterine infection, which might not be detectable by CMA or WES. WGS also required less DNA (100 ng) as input and could provide a rapid turnaround time (TAT, 18 ± 6 days) compared with that (31 ± 8 days) of the CMA plus WES. Our results showed that WGS provided more comprehensive and precise genetic information with a rapid TAT and less DNA required than CMA plus WES, which enables it as an alternative prenatal diagnosis test for fetal structural anomalies.

Indexed as

Abnormalities, MultipleChromosomes, HumanExome SequencingFemaleGestational AgeHumansMicroarray AnalysisPregnancyPregnancy Trimester, FirstPrenatal DiagnosisProspective StudiesWhole Genome Sequencingchromosomal microarrayfetal structural anomaliesprenatal diagnosiswhole exome sequencingwhole genome sequencing

Identifiers

PMID33800913
PMCPMC7999180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.